Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.68

+0.1%

Nov 28 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (842)	7/18/2005 10:15:39 AM
From: Jibacoa	Read Replies (2) of 3722

MLNM Is going over its June 20 H of 10.01 and hasn't bothered to close its June 17 upgap.<g> bigcharts.marketwatch.com Last Monday it announced that it was starting a PII of MLN1202, its humanized monoclonal antibody, in patients with relapsing-remitting MS MLN1202 is supposed to block CCR2 chemokine receptors and to prevent the infiltration of immune cells into inflammatory sites. MLNM Reportedly has around $1.85 in cash/shr and is expected to cut its loss to $0.35/shr vs. $0.59 in 2004 and for 2006 a further cut is expected to $0.07/shr.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next